163 related articles for article (PubMed ID: 29332600)
1. Finding Novel Anti-carcinomas Compounds by Targeting SFRP4 Through Molecular Modeling, Docking and Dynamic Simulation Studies.
Hassan M; Azhar M; Abbas Q; Raza H; Moustafa AA; Shahzadi S; Ashraf Z; Seo SY
Curr Comput Aided Drug Des; 2018; 14(2):160-173. PubMed ID: 29332600
[TBL] [Abstract][Full Text] [Related]
2. Exploration of Novel Human Tyrosinase Inhibitors by Molecular Modeling, Docking and Simulation Studies.
Hassan M; Ashraf Z; Abbas Q; Raza H; Seo SY
Interdiscip Sci; 2018 Mar; 10(1):68-80. PubMed ID: 27098808
[TBL] [Abstract][Full Text] [Related]
3. In Silico identification of novel phytochemicals that target SFRP4: An early biomarker of diabesity.
Rehman A; Bukhari SA; Akhter N; Ijaz Hussain MA; Chauhdary Z
PLoS One; 2023; 18(11):e0292155. PubMed ID: 37943820
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study.
Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY
Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400
[TBL] [Abstract][Full Text] [Related]
5. Computer aided screening of secreted frizzled-related protein 4 (SFRP4): a potential control for diabetes mellitus.
Bukhari SA; Shamshari WA; Ur-Rahman M; Zia-Ul-Haq M; Jaafar HZ
Molecules; 2014 Jul; 19(7):10129-36. PubMed ID: 25019556
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
[TBL] [Abstract][Full Text] [Related]
7. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
Arodola OA; Soliman ME
Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
[TBL] [Abstract][Full Text] [Related]
8. Secreted frizzled-related protein 4 expression is positively associated with responsiveness to cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers.
Saran U; Arfuso F; Zeps N; Dharmarajan A
BMC Cell Biol; 2012 Oct; 13():25. PubMed ID: 23039795
[TBL] [Abstract][Full Text] [Related]
9. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
[TBL] [Abstract][Full Text] [Related]
10. Expression of secreted frizzled-related protein 4 (SFRP4) in primary serous ovarian tumours.
Drake J; Shearwood AM; White J; Friis R; Zeps N; Charles A; Dharmarajan A
Eur J Gynaecol Oncol; 2009; 30(2):133-41. PubMed ID: 19480240
[TBL] [Abstract][Full Text] [Related]
11. Molecular Interaction and Computational Analytical Studies of Pinocembrin for its Antiangiogenic Potential Targeting VEGFR-2: A Persuader of Metastasis.
Sharma N; Sharma M; Shakeel E; Jamal QMS; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM; Akhtar S
Med Chem; 2018; 14(6):626-640. PubMed ID: 29663896
[TBL] [Abstract][Full Text] [Related]
12. Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy.
Ghoshal A; Ghosh SS
Mol Cell Biochem; 2016 Jul; 418(1-2):119-35. PubMed ID: 27334754
[TBL] [Abstract][Full Text] [Related]
13. Computational Studies in Drug Design Against Cancer.
De B; Bhandari K; Mendonça FJB; Scotti MT; Scotti L
Anticancer Agents Med Chem; 2019; 19(5):587-591. PubMed ID: 30207247
[TBL] [Abstract][Full Text] [Related]
14. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from Nigella sativa L. that Inhibits P38 Protein: Probable Remedies for Hepatocellular Carcinoma.
Tabassum H; Ahmad IZ
Med Chem; 2020; 16(3):350-357. PubMed ID: 31038073
[TBL] [Abstract][Full Text] [Related]
15. Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.
Abbasi M; Sadeghi-Aliabadi H; Amanlou M
Daru; 2017 Jun; 25(1):17. PubMed ID: 28666484
[TBL] [Abstract][Full Text] [Related]
16. Performance of a docking/molecular dynamics protocol for virtual screening of nutlin-class inhibitors of Mdmx.
Bharatham N; Finch KE; Min J; Mayasundari A; Dyer MA; Guy RK; Bashford D
J Mol Graph Model; 2017 Jun; 74():54-60. PubMed ID: 28351017
[TBL] [Abstract][Full Text] [Related]
17. In Silico Structural, Virtual Screening and Docking Studies of Human Cytochrome P450 2A7 Protein.
Lodhi SS; Farmer R; Jaiswal YK; Wadhwa G
Interdiscip Sci; 2015 Jun; 7(2):129-35. PubMed ID: 26239541
[TBL] [Abstract][Full Text] [Related]
18. In silico molecular docking and dynamic simulation of eugenol compounds against breast cancer.
Rasul HO; Aziz BK; Ghafour DD; Kivrak A
J Mol Model; 2021 Dec; 28(1):17. PubMed ID: 34962586
[TBL] [Abstract][Full Text] [Related]
19. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells.
Carmon KS; Loose DS
Mol Cancer Res; 2008 Jun; 6(6):1017-28. PubMed ID: 18567805
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, biological evaluation and molecular modeling of novel 2-amino-4-(1-phenylethoxy) pyridine derivatives as potential ROS1 inhibitors.
Tian Y; Zhang T; Long L; Li Z; Wan S; Wang G; Yu Y; Hou J; Wu X; Zhang J
Eur J Med Chem; 2018 Jan; 143():182-199. PubMed ID: 29174814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
